REG - PureTech Health PLC - Transaction in Own Shares
06/11/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231106:nRSF4075Sa&default-theme=true
RNS Number : 4075S PureTech Health PLC 06 November 2023
6 November 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 3 November 2023
Number of ordinary shares purchased: 38,688
Highest price paid per share: 161.60p
Lowest price paid per share: 154.00p
Volume weighted average price paid per share: 158.90p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 16,085,241 ordinary
shares in treasury and has 273,382,918 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,382,918 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
03/11/2023 08:29:21 87 161.6 XLON 00377058641TRLO0.1.1
03/11/2023 08:29:21 197 161.6 XLON 00377058642TRLO0.1.1
03/11/2023 08:29:24 284 161.4 CHIX 00377058647TRLO0.1.1
03/11/2023 08:29:24 91 160.4 TRQX 00377058648TRLO0.1.1
03/11/2023 08:39:05 284 159 BATE 00377060780TRLO0.1.1
03/11/2023 09:06:38 261 159 XLON 00377066232TRLO0.1.1
03/11/2023 09:10:31 284 159 XLON 00377066902TRLO0.1.1
03/11/2023 09:10:31 23 159 XLON 00377066903TRLO0.1.1
03/11/2023 09:10:31 284 159 XLON 00377066904TRLO0.1.1
03/11/2023 09:10:31 188 159 XLON 00377066905TRLO0.1.1
03/11/2023 09:13:21 380 159.8 XLON 00377067246TRLO0.1.1
03/11/2023 09:13:21 284 159.8 BATE 00377067245TRLO0.1.1
03/11/2023 09:13:25 16 158.8 AQXE 00377067277TRLO0.1.1
03/11/2023 09:13:25 284 159 CHIX 00377067278TRLO0.1.1
03/11/2023 09:13:25 117 158.8 AQXE 00377067280TRLO0.1.1
03/11/2023 09:13:25 52 159 CHIX 00377067279TRLO0.1.1
03/11/2023 09:29:37 53 159.6 XLON 00377069993TRLO0.1.1
03/11/2023 09:29:37 284 159.6 XLON 00377069995TRLO0.1.1
03/11/2023 09:29:37 515 159.6 XLON 00377069994TRLO0.1.1
03/11/2023 09:29:37 284 159.6 XLON 00377069996TRLO0.1.1
03/11/2023 09:29:37 284 159.6 XLON 00377069997TRLO0.1.1
03/11/2023 09:38:11 89 158.8 AQXE 00377071283TRLO0.1.1
03/11/2023 09:38:11 222 158.8 AQXE 00377071284TRLO0.1.1
03/11/2023 09:38:11 100 158.8 AQXE 00377071285TRLO0.1.1
03/11/2023 09:38:11 284 158.8 BATE 00377071286TRLO0.1.1
03/11/2023 09:38:11 63 158.8 BATE 00377071287TRLO0.1.1
03/11/2023 09:38:11 91 158.8 TRQX 00377071288TRLO0.1.1
03/11/2023 09:38:11 284 158.8 XLON 00377071289TRLO0.1.1
03/11/2023 09:38:11 284 158.8 XLON 00377071291TRLO0.1.1
03/11/2023 09:38:11 568 158.8 XLON 00377071290TRLO0.1.1
03/11/2023 09:38:13 220 158.2 XLON 00377071303TRLO0.1.1
03/11/2023 09:46:33 284 157.6 XLON 00377072288TRLO0.1.1
03/11/2023 09:46:33 82 157.4 XLON 00377072290TRLO0.1.1
03/11/2023 09:46:33 348 157.6 XLON 00377072289TRLO0.1.1
03/11/2023 10:13:04 177 157.8 XLON 00377075883TRLO0.1.1
03/11/2023 10:37:31 284 158 CHIX 00377079239TRLO0.1.1
03/11/2023 10:37:31 90 158 XLON 00377079241TRLO0.1.1
03/11/2023 10:37:31 777 158 XLON 00377079240TRLO0.1.1
03/11/2023 10:37:31 553 158 XLON 00377079242TRLO0.1.1
03/11/2023 10:49:51 877 157.6 XLON 00377080600TRLO0.1.1
03/11/2023 10:49:51 232 157.6 CHIX 00377080599TRLO0.1.1
03/11/2023 10:49:51 5 157.4 XLON 00377080602TRLO0.1.1
03/11/2023 10:49:51 284 157.6 XLON 00377080601TRLO0.1.1
03/11/2023 10:49:51 13 157.4 XLON 00377080603TRLO0.1.1
03/11/2023 10:49:51 75 157.4 XLON 00377080604TRLO0.1.1
03/11/2023 10:49:51 4 157.4 XLON 00377080605TRLO0.1.1
03/11/2023 10:49:51 37 157.4 XLON 00377080606TRLO0.1.1
03/11/2023 10:49:51 221 157 BATE 00377080607TRLO0.1.1
03/11/2023 10:49:51 284 157 BATE 00377080608TRLO0.1.1
03/11/2023 10:49:52 91 157 TRQX 00377080609TRLO0.1.1
03/11/2023 11:01:57 284 156 CHIX 00377082141TRLO0.1.1
03/11/2023 11:38:18 39 155.4 XLON 00377086447TRLO0.1.1
03/11/2023 11:38:18 434 155.4 XLON 00377086446TRLO0.1.1
03/11/2023 11:38:18 110 155.4 XLON 00377086448TRLO0.1.1
03/11/2023 11:38:18 245 155.4 XLON 00377086449TRLO0.1.1
03/11/2023 11:38:18 93 155.4 XLON 00377086450TRLO0.1.1
03/11/2023 11:38:18 81 155.4 XLON 00377086451TRLO0.1.1
03/11/2023 11:38:26 284 154.6 BATE 00377086461TRLO0.1.1
03/11/2023 11:38:26 260 154.6 CHIX 00377086462TRLO0.1.1
03/11/2023 11:38:26 24 154.6 CHIX 00377086463TRLO0.1.1
03/11/2023 11:40:19 236 154 AQXE 00377086674TRLO0.1.1
03/11/2023 11:43:16 568 155.2 XLON 00377086973TRLO0.1.1
03/11/2023 11:55:05 1420 154.2 XLON 00377088317TRLO0.1.1
03/11/2023 12:26:17 91 156 TRQX 00377092215TRLO0.1.1
03/11/2023 12:40:19 200 156 CHIX 00377094980TRLO0.1.1
03/11/2023 12:40:19 84 156 CHIX 00377094981TRLO0.1.1
03/11/2023 12:40:19 91 156 TRQX 00377094982TRLO0.1.1
03/11/2023 12:40:32 3976 155.6 XLON 00377095009TRLO0.1.1
03/11/2023 13:57:26 53 159 XLON 00377115013TRLO0.1.1
03/11/2023 13:58:44 424 159 CHIX 00377115510TRLO0.1.1
03/11/2023 13:58:44 313 159 XLON 00377115511TRLO0.1.1
03/11/2023 14:00:21 1338 160.6 XLON 00377116314TRLO0.1.1
03/11/2023 14:26:35 76 161.2 XLON 00377135348TRLO0.1.1
03/11/2023 14:26:35 568 161.2 XLON 00377135347TRLO0.1.1
03/11/2023 14:26:35 12 161 CHIX 00377135350TRLO0.1.1
03/11/2023 14:26:35 231 161 CHIX 00377135349TRLO0.1.1
03/11/2023 14:26:35 113 161 CHIX 00377135351TRLO0.1.1
03/11/2023 15:21:19 53 161.4 XLON 00377177200TRLO0.1.1
03/11/2023 15:21:19 439 161.4 XLON 00377177201TRLO0.1.1
03/11/2023 15:21:19 284 161.4 XLON 00377177202TRLO0.1.1
03/11/2023 15:21:19 84 161.4 XLON 00377177204TRLO0.1.1
03/11/2023 15:21:19 200 161.4 XLON 00377177203TRLO0.1.1
03/11/2023 15:21:19 7 161.4 XLON 00377177205TRLO0.1.1
03/11/2023 15:21:19 38 161 TRQX 00377177207TRLO0.1.1
03/11/2023 15:21:19 277 161.4 XLON 00377177206TRLO0.1.1
03/11/2023 15:21:19 25 161 CHIX 00377177208TRLO0.1.1
03/11/2023 15:21:19 44 161 TRQX 00377177210TRLO0.1.1
03/11/2023 15:21:19 9 161 TRQX 00377177209TRLO0.1.1
03/11/2023 15:30:20 331 161 CHIX 00377180159TRLO0.1.1
03/11/2023 15:30:20 13 161 CHIX 00377180161TRLO0.1.1
03/11/2023 15:30:20 53 161 CHIX 00377180160TRLO0.1.1
03/11/2023 15:30:20 92 160.8 XLON 00377180162TRLO0.1.1
03/11/2023 15:30:20 760 160.8 XLON 00377180163TRLO0.1.1
03/11/2023 15:30:20 216 161 AQXE 00377180164TRLO0.1.1
03/11/2023 15:37:10 617 160.8 XLON 00377182263TRLO0.1.1
03/11/2023 15:37:10 21 160.8 XLON 00377182264TRLO0.1.1
03/11/2023 15:38:26 498 160.6 XLON 00377182641TRLO0.1.1
03/11/2023 15:38:26 366 160.6 XLON 00377182642TRLO0.1.1
03/11/2023 15:57:13 218 160.8 CHIX 00377189355TRLO0.1.1
03/11/2023 15:57:13 284 160.8 CHIX 00377189356TRLO0.1.1
03/11/2023 15:57:13 244 160.8 XLON 00377189357TRLO0.1.1
03/11/2023 15:57:13 284 160.8 XLON 00377189358TRLO0.1.1
03/11/2023 15:57:13 220 160.8 XLON 00377189359TRLO0.1.1
03/11/2023 15:57:13 284 160.8 XLON 00377189360TRLO0.1.1
03/11/2023 15:57:13 202 160.8 XLON 00377189361TRLO0.1.1
03/11/2023 15:57:13 672 160.8 XLON 00377189362TRLO0.1.1
03/11/2023 15:59:04 676 160.6 XLON 00377189914TRLO0.1.1
03/11/2023 15:59:04 91 160.6 XLON 00377189919TRLO0.1.1
03/11/2023 15:59:04 3 160.6 XLON 00377189920TRLO0.1.1
03/11/2023 15:59:34 284 160.6 CHIX 00377190133TRLO0.1.1
03/11/2023 15:59:34 1786 160.6 XLON 00377190134TRLO0.1.1
03/11/2023 15:59:34 500 160.4 XLON 00377190136TRLO0.1.1
03/11/2023 15:59:34 770 160.6 XLON 00377190135TRLO0.1.1
03/11/2023 15:59:34 58 160.2 TRQX 00377190137TRLO0.1.1
03/11/2023 15:59:34 5 160.2 TRQX 00377190138TRLO0.1.1
03/11/2023 16:07:00 478 160.8 XLON 00377192709TRLO0.1.1
03/11/2023 16:09:10 22 160.2 AQXE 00377193439TRLO0.1.1
03/11/2023 16:09:10 19 160.2 AQXE 00377193440TRLO0.1.1
03/11/2023 16:20:50 568 160.8 CHIX 00377198040TRLO0.1.1
03/11/2023 16:20:50 131 160.8 CHIX 00377198041TRLO0.1.1
03/11/2023 16:20:50 1971 160.8 XLON 00377198043TRLO0.1.1
03/11/2023 16:20:50 153 160.8 CHIX 00377198042TRLO0.1.1
03/11/2023 16:21:03 180 160.8 XLON 00377198142TRLO0.1.1
03/11/2023 16:21:03 1024 160.8 XLON 00377198143TRLO0.1.1
03/11/2023 16:21:03 27 160.8 XLON 00377198144TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFSALELVIIVRecent news on Puretech Health
See all newsRCS - PureTech Health PLC - PRTC to Present at Jefferies Healthcare Conference
AnnouncementRCS - PureTech Health PLC - PRTC's Vedanta Begins Phase 3 of VE303 in C. diff
AnnouncementREG - PureTech Health PLC - Tender Offer
AnnouncementRCS - PureTech Health PLC - PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data
AnnouncementRCS - PureTech Health PLC - PRTC's Seaport Announces Board/Team Appointments
Announcement